Annual Drug Patent Expirations for REYATAZ Reyataz is a drug marketed by Bristol Myers Squibb and is included in two NDAs. It is available from six suppliers. There are two…
The post New patent expiration for Bristol Myers drug REYATAZ appeared f…
New patent expiration for Bristol Myers drug REYATAZ Read Post »
This article was originally published on November 30th 2017 by Hamish McDougall and Alaric DeArment of BioPharm Insight, part of GlobalData. Polymorph differences support noninfringement argument Trace solvate amount could destabalise…
The post C…
Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30+PENFILL Novolog Mix 70/30 Penfill is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers.…
The post New patent expiration for Novo Nordisk drug …
New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 PENFILL Read Post »
Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30+FLEXPEN Novolog Mix 70/30 Flexpen is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers.…
The post New patent expiration for Novo Nordisk drug …
New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 FLEXPEN Read Post »
Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30 Novolog Mix 70/30 is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There…
The post New patent expiration for Novo Nordisk drug NOVOLOG MI…
New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 Read Post »
Annual Drug Patent Expirations for LOTREL Lotrel is a drug marketed by Novartis and is included in one NDA. It is available from eight suppliers. There is one patent protecting…
The post New patent expiration for Novartis drug LOTREL appeared fir…
QVAR 80 (beclomethasone dipropionate) Teva branded pharm Patent: 6,446,627 Expiration: Dec 18, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent …
Drug Patent Expirations for the Week of December 17, 2017 Read Post »
Annual Drug Patent Expirations for EXFORGE+HCT Exforge Hct is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Novartis drug EXFORGE HCT appeared first …
New patent expiration for Novartis drug EXFORGE HCT Read Post »
Annual Drug Patent Expirations for EXFORGE Exforge is a drug marketed by Novartis and is included in two NDAs. It is available from three suppliers. There are four patents protecting…
The post New patent expiration for Novartis drug EXFORGE appea…
Annual Drug Patent Expirations for ESBRIET Esbriet is a drug marketed by Genentech Inc and is included in two NDAs. It is available from one supplier. There are twenty-one patents…
The post New patent expiration for Genentech Inc drug ESBRIET appeared …
New patent expiration for Genentech Inc drug ESBRIET Read Post »
Get new actionable insights and updates from BiotechBlog
